Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
Lowe's Companies
LOW
$121B
| $6.97M | 0.13% |
58,211
-315,195
| -84% | -$36M |
|
227
Ingersoll Rand
IR
$31B
| $6.93M | 0.13% |
188,886
-103,699
| -35% | -$3.4M |
|
228
Armstrong World Industries
AWI
$7.53B
| $6.92M | 0.13% |
73,696
+10,173
| +16% | +$972K |
|
|
ABMD
229
DELISTED
Abiomed Inc
ABMD
| $6.89M | 0.13% |
40,371
+37,586
| +1,350% | +$6.97M |
|
230
Lattice Semiconductor
LSCC
$16.3B
| $6.8M | 0.12% |
355,369
+66,724
| +23% | +$1.28M |
|
231
Stanley Black & Decker
SWK
$14.9B
| $6.79M | 0.12% |
40,985
-7,506
| -15% | -$1.16M |
|
232
Costco
COST
$430B
| $6.78M | 0.12% |
23,049
+8,344
| +57% | +$2.48M |
|
233
CBRE Group
CBRE
$43.6B
| $6.7M | 0.12% |
109,248
+98,515
| +918% | +$5.46M |
|
234
Nucor
NUE
$55.9B
| $6.62M | 0.12% |
117,640
+1,390
| +1% | +$75.8K |
|
235
Advance Auto Parts
AAP
$2.63B
| $6.53M | 0.12% |
40,763
+31,710
| +350% | +$5.08M |
|
236
NCR Voyix
VYX
$1.09B
| $6.51M | 0.12% |
301,979
+115,712
| +62% | +$2.25M |
|
237
Hartford Financial Services
HIG
$37.6B
| $6.51M | 0.12% |
107,092
+55,818
| +109% | +$3.35M |
|
238
Allegion
ALLE
$13.8B
| $6.46M | 0.12% |
+51,896
| New | +$5.99M |
|
239
Nasdaq
NDAQ
$54.9B
| $6.46M | 0.12% |
180,939
+12,162
| +7% | +$415K |
|
|
WCG
240
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.35M | 0.12% |
19,217
+15,170
| +375% | +$4.55M |
|
241
Wells Fargo
WFC
$255B
| $6.24M | 0.11% |
116,044
+54,093
| +87% | +$2.83M |
|
242
Landstar System
LSTR
$6.09B
| $6.24M | 0.11% |
54,756
-14,192
| -21% | -$1.6M |
|
|
ECHO
243
EchoStar
ECHO
$24.9B
| $6.2M | 0.11% |
143,247
+45,631
| +47% | +$1.83M |
|
|
HMSY
244
DELISTED
HMS Holdings Corp.
HMSY
| $6.16M | 0.11% |
208,034
-79,631
| -28% | -$2.44M |
|
245
United Therapeutics
UTHR
$22B
| $6.09M | 0.11% |
69,191
+21,574
| +45% | +$1.9M |
|
246
Danaher
DHR
$151B
| $6.06M | 0.11% |
44,558
-15,243
| -25% | -$1.93M |
|
247
Halliburton
HAL
$28.7B
| $6.03M | 0.11% |
+246,529
| New | +$5.2M |
|
248
Conagra Brands
CAG
$8.01B
| $6.02M | 0.11% |
175,862
-95,971
| -35% | -$2.78M |
|
249
TransUnion
TRU
$16.1B
| $6.01M | 0.11% |
70,209
+19,562
| +39% | +$1.63M |
|
250
VeriSign
VRSN
$26.4B
| $5.84M | 0.11% |
30,299
-14,133
| -32% | -$2.66M |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.